Archive
Back to homepageADA CELEBRATES RECORD-BREAKING FIVE YEARS
The company achieved five times growth in top line revenue, serving over 3,000+ large brands and developed 1,200 digital talents across 11 countries SINGAPORE, March 29, 2023 /PRNewswire/ — Integrated growth agency ADA celebrated its momentous 5-year anniversary today. Formed in 2018,
Read MoreLotus Technology begins delivery of Eletre luxury electric SUV
NEW YORK, March 30, 2023 /PRNewswire/ — Today, Lotus Technology Inc. (“Lotus Tech” or the “Company”), a leading global luxury electric vehicle maker, successfully completed its first delivery of Eletre, its first fully electric hyper SUV. Lotus Tech hosted a
Read MoreTo become the Smart Application Exporting country – 2023 World System Integrator Conference opens a new era
2023 WSIC Transforms Taiwan into an Exporter of Smart Applications TAIPEI, March 30, 2023 /PRNewswire/ — The 2023 World System Integrator Conference (WSIC) was hosted by the Administration for Digital Industries (adi), Ministry of Digital Affairs (moda), at the Nangang Exhibition
Read MoreJW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients
SHANGHAI, March 30, 2023 /PRNewswire/ — JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that as of March 29, 2023, the company has conducted 13 clinical studies covering
Read MoreVymo recognized in the 2023 Gartner® Market Guide for Sales Engagement Applications
SINGAPORE, March 30, 2023 /PRNewswire/ — Vymo, the leading Sales Engagement Platform for Financial Institutions, has been recognized in the Gartner Market Guide for Sales Engagement Applications for the second time. The 2023 report provides objective insights to CXOs, Business, and
Read MoreImmVira’s oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA’s approval for Clinical Trial in China
SHENZHEN, China, March 30, 2023 /PRNewswire/ — ImmVira announced that its oncolytic virus product MVR-C5252 targeting malignant glioma obtained the approval from National Medical Products Administration (“NMPA”) for Phase I clinical trial in China on March 29, 2023. Previously, MVR-C5252
Read MoreSOR Moisture Energy to Exceed Solar Power Density
PERTH, Australia, March 30, 2023 /PRNewswire/ — Strategic Elements Ltd (ASX: SOR) is pleased to announce that the Energy InkTM technology is on track to exceed the power density of solar technology due to technical breakthroughs in the process of
Read MoreCoachHub Introduces AIMY™, First Conversational AI Career Coach
Global digital coaching leader leverages generative AI to create AI-powered coaching sessions with multilingual voice recognition. TOKYO, March 30, 2023 /PRNewswire/ — CoachHub, the leading global digital coaching platform, today unveils AIMY™, a personalized conversational AI career coach. AIMY™ is powered
Read MoreAxi extends multi-year partnership deal with Man City
Axi renews multi-year deal with Manchester City and expands rights with the addition of Manchester City women’s team. Promotes competitive Copy Trading offer, revamped Axi Elite offering and an expanded range of asset classes. SYDNEY, March 30, 2023 /PRNewswire/ —
Read MoreGrant Weinstein joins Performio as Head of Sales, APAC — Performio Strengthens Global Sales Leadership Team
Grant brings 20 years of business development and sales management to help drive the next stage of Performio’s APAC Growth IRVINE, Calif. and MELBOURNE, Australia, March 30, 2023 /PRNewswire/ — Performio, a leading incentive compensation management (ICM) provider, announced today
Read More
